BUFFALO, N.Y. -- Specialists in neuroimaging at the University at Buffalo have proposed a mechanism by which interferon beta-1a may limit brain atrophy in multiple sclerosis (MS) patients. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback